Skip to main content
Clinical Trials/CTRI/2023/08/056505
CTRI/2023/08/056505
Not yet recruiting
Phase 2

Efficacy and Safety of Intranasal Application of Human Milk for Neuroprotection in Neonates with Hypoxic Ischemic Encephalopathy: A Pilot Randomized Controlled Trial - NI

Banaras Hindu University0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: P969- Condition originating in the perinatal period, unspecified
Sponsor
Banaras Hindu University
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Term or post term neonates will be recruited to the trial if they meet both of the following two criteria of eligibility: first, a need for continued resuscitation at 5 min of age or an Apgar score of less than 6 at 5 min of age (for babies born in a hospital), or both, or an absence of crying by 5 min of age (for babies born at home); and second, evidence of encephalopathy based on clinical examination using modified Sarnat staging

Exclusion Criteria

  • 1\. Chromosomal anomalies
  • 2\. Major congenital malformation
  • 3\. Microcephaly
  • 4\. Dysmorphic features
  • 5\. Suspected intrauterine infection
  • 6\.Failure to obtain consent

Outcomes

Primary Outcomes

Not specified

Similar Trials